Robert Barrow, CEO: Definium Therapeutics DFTX Sell · Filed 25/12/29

Trade details

Type: Insider sale
Amount: $339,151.65
Shares · price: 25,791 sh · $13.15 a share
Held after: 778,477 sh
Stock: Definium Therapeutics DFTX
Person: Robert BarrowCEO
Trade date: 25/12/26
Filed: 25/12/29
Days to filing: 3 days

Sold 3.2% of holdings

Share of holding sold: 3.2%

Definium Therapeutics trades, last 26 weeks

What else happened in Definium Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/26~01/25

Robert Barrow's recent trades

Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/29
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/25
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$718.1K
19,023 sh
$718.1K
Filed 09/03
Traded 09/03
Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.3M
29,208 sh
$1.3M
Filed 06/26
Traded 06/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
29,208 sh
$1.2M
Filed 06/25
Traded 06/25

Robert Barrow, CEO — sold $339.2K of Definium Therapeutics DFTX · 3.2% of holdings · 10b5-1 plan | Whalegun